Is epithalon legal to buy in the United States?

Sale as a research chemical, labelled for laboratory use and not for human consumption, is the channel that operates and it is not hidden. There is no FDA approval for epithalon for any indication and no lawful compounded preparation, so there is no medical route to compare it against. We describe the position rather than advise on it, and personal circumstances vary.

Can a doctor prescribe epithalon if I ask?

There is nothing lawful to prescribe. A prescription has to be filled from an approved product or a compliant compounded preparation, and epitalon is neither, because its bulks list nomination was withdrawn and it appears on no current category of that list as of the FDA's 14 May 2026 update.

Is epithalon banned or is it category 2?

Neither statement is accurate today. It was placed in category 2 under the FDA's interim policies while the nomination was evaluated, and the nomination was then withdrawn by the nominator, which is the nominator stopping rather than the agency prohibiting. It now sits on the separate list of substances nominated but withdrawn and on no current category list.

Why do some clinics advertise epithalon if no prescriber can write for it?

Because a longevity or anti-ageing clinic operates as a cash wellness business and its menu is not constrained the way a pharmacy's is. If you meet one offering it, ask where the material came from, whether a certificate exists for that specific lot, and whether it includes an endotoxin result. Those three questions separate the operations that have checked from the ones that have not.

Is buying epitalon without prescription different from buying epithalon?

No. The two spellings refer to the same molecule, PubChem CID 219042. Regulatory documents use Epitalon and storefronts use Epithalon, which is why searching only one spelling gives you half the picture.

Does the research-use label mean the seller is doing something underhand?

Not by itself. It is the accurate legal description of what is being sold and a seller who sticks to it is being straight with you. The signal to watch for is the opposite: a research-use legend on the vial and human dosing advice on the website, which means the seller knows the rules and has decided the marketing matters more.

Epithalon Without Prescription: No Script Exists to Skip

Summary: There is no prescription for epithalon anywhere in the United States, so buying it without one is not a workaround but a description of the only channel that exists.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Buying epithalon without prescription sounds like a shortcut around a gate. There is no gate. No doctor in the United States can write a prescription for this compound, no pharmacy can fill one, and the phrase describes the only way the substance changes hands rather than an alternative to some official route. This page sets out exactly why, with the dates.

The listing this page refers to is on the card below.

Where readers actually buy it

Ascension Peptides — Epithalon

Research-grade Epithalon, tested by two outside labs and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off

Epithalon · 10 mg$50.00$25.00$2.50/mgGet the 10 mg →

The certificate for batch 15-05260628 assays this vial at 9.64 mg against a 10 mg label, inside the stated 10 percent tolerance, which puts the real figure at $2.59/mg on that batch. It carries purity, identity, endotoxin, sterility and heavy metals. Buying 3, 5 or 10 takes 3%, 5% or 10% off list.

Batch certificates from two independent labs
Free shipping over $250
Ships same day if ordered before 2pm CST

Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 23, 2026.

This is the most careful page in our epithalon coverage, because the regulatory position is widely misreported and the errors run in both directions.

What epithalon is, since the answer depends on it

Epithalon is a synthetic tetrapeptide: four amino acids in the order Ala-Glu-Asp-Gly, abbreviated AEDG. Formula C14H22N4O9, molecular weight 390.35, PubChem CID 219042 ^[4]. It was developed in Russia by Vladimir Khavinson's group as a synthetic version of a fraction of a pineal gland extract called epithalamin.

The FDA and PubChem write it Epitalon. The buying market writes it Epithalon. They are two transliterations of one Russian name for one molecule, and every regulatory document quoted below uses the first spelling while every storefront uses the second.

It is not a GLP-1, not an incretin and not a weight-loss drug, which is worth stating on this site because most readers arrive from the incretin coverage. The claims that carry its marketing concern telomeres, telomerase and longevity, and they rest on a research literature that is largely Russian-language and largely from a single group, with more recent laboratory work reporting effects in cultured human cells. Reporting the existence of those claims is accurate. Presenting them as established in people is not, and no Western regulator has done so.

Epithalon without prescription: three things the phrase can mean

Reading	Is it true of epithalon	Why
There is no prescription requirement, like a supplement	No	It is not a dietary ingredient and it is not sold as food or a supplement. It is sold as a research chemical, which is a different category with different rules
A prescription exists and buyers are bypassing it	No	Nothing exists to bypass. There is no approved product and no lawful compounded preparation, so no prescriber has anything to write
No prescription is possible, so the only channel is research-use sale	Yes	This is the accurate reading, and every other statement on this page follows from it

The distinction is not pedantry. Readers who assume the second reading go looking for a telehealth service willing to write for epithalon, find one advertising something adjacent, and end up in a transaction where the marketing is the only thing that changed.

The regulatory position, in order and with dates

No approval. There is no FDA-approved drug product containing epitalon for any indication. There is no approval in the European Union, the United Kingdom, Canada or Australia either. Registration in Russia, where several Khavinson peptides have a regulatory history, is a fact about Russian regulation and creates nothing anywhere else.

The compounding route, and how it closed. Compounding pharmacies operating under section 503A of the Federal Food, Drug, and Cosmetic Act may compound from a bulk drug substance only in defined circumstances, one of which is that the substance appears on the FDA's 503A bulks list ^[3]. Substances get onto that list by nomination and evaluation. During that process the agency sorts nominations into interim categories, and category 2 is where it places substances it has identified as raising potential significant safety risks ^[1].

Epitalon was nominated. It was placed in category 2 under the interim policies. The nomination was then withdrawn by the nominator, which stopped the evaluation rather than concluding it. The FDA's safety-risks page, content current as of 22 April 2026, carries epitalon in a table headed "Bulk drug substances nominated but withdrawn", which the page itself describes as a list of substances "previously in category 2 of the interim policies" that "were withdrawn by the nominators" ^[1]. Separately, the 503A bulks list page, content current as of 14 May 2026, does not contain epitalon at all, in Category 1, Category 2 or Category 3 ^[2].

What that does to the chain. A pharmacy with no listed bulk substance has nothing compliant to compound from. A prescriber with no lawful preparation to order has nothing to write for. A clinic with no prescriber able to write has nothing to put on a menu. The chain breaks at the first link and everything downstream of it is empty. The same structure appears in our pages on semax without prescription and selank without prescription, because all three are Russian peptides with the same withdrawn-nomination history.

It is worth contrasting that with a compound in a genuinely different position. Our page on NAD+ without prescription covers a substance that does appear on a current category of the bulks list, and even there the point has to be made that a listing is not an approval. Epithalon does not get as far as the listing.

What a research-use sale actually is

The vial is labelled for laboratory research use and not for human consumption. That legend is not decoration and it is not a wink. It is the basis on which the sale sits outside drug marketing altogether. A seller who keeps to it is offering a chemical to a laboratory. A seller who attaches human dosing, therapeutic claims or before-and-after imagery to the same vial has stepped into marketing an unapproved new drug, which is a different legal position entirely and a reliable signal about how the rest of that operation is run.

For the buyer this has three consequences worth being blunt about.

No clinical oversight of any kind. No prescriber assessing whether the compound suits you, no pharmacist checking interactions, no monitoring and no follow-up. Nobody in the transaction has taken responsibility for you, because the sale is not framed as being for you.
No manufacturing standard is promised. Approved drugs are made under current good manufacturing practice requirements enforced by inspection. Research chemicals are not, and a certificate of analysis is a test report on a sample, not evidence of a quality system.
No recourse over the contents. Sealed and unopened returns within a window, sometimes. Anything else, effectively never.

Where the withdrawal leaves a buyer

With one channel and one document. The channel is a research supplier. The document is the certificate of analysis for the batch you are shipped, and it is the only thing standing between an ordinary purchase and an entirely unverified one.

For the current lot at the vendor on the card, that document is batch 15-05260628, run by Kovera Labs, certified 23 May 2026 under report KVR-2026-A36FF4. It reports purity of 99.312% against a greater-than-98% specification, by reversed-phase HPLC on a C18 column with diode array detection at 214 nm. Identity confirmed by LC-MS. An endotoxin safety screen against a 0.5 EU/mL limit, result PASS. A microbial sterility screen returning no growth. Arsenic, cadmium, lead and mercury all negative. And a net content of 9.64 mg in a vial labelled 10 mg, against a stated specification of 10 mg plus or minus 10 percent ^[5].

Two things about that document deserve saying together. It is more complete than most certificates in this market, and it publishes a fill weight that works slightly against the seller, moving the real cost from $2.50 to $2.59 per milligram at the discounted price. That is what a measurement looks like rather than a marketing figure. At the same time, the endotoxin line is a pass or fail entry with no measured value and no compendial method named, where a fuller result would be a kinetic chromogenic LAL assay run to USP Chapter 85 with a number attached. And there is only one certificate published for this compound, so there is no second lot to compare it against.

None of that converts into a safety claim, and this is the sentence the page turns on. A clean certificate answers questions about a batch. The FDA is not asking a question about a batch. It is saying that the information needed to know whether this substance harms people has not been identified, and no laboratory report can supply data that nobody has generated.

Common questions about epithalon without a prescription

Is epithalon legal to buy in the United States?: Sale as a research chemical, labelled for laboratory use and not for human consumption, is the channel that operates and it is not hidden. There is no FDA approval for epithalon for any indication and no lawful compounded preparation, so there is no medical route to compare it against. We describe the position rather than advise on it, and personal circumstances vary.
Can a doctor prescribe epithalon if I ask?: There is nothing lawful to prescribe. A prescription has to be filled from an approved product or a compliant compounded preparation, and epitalon is neither, because its bulks list nomination was withdrawn and it appears on no current category of that list as of the FDA's 14 May 2026 update.
Is epithalon banned or is it category 2?: Neither statement is accurate today. It was placed in category 2 under the FDA's interim policies while the nomination was evaluated, and the nomination was then withdrawn by the nominator, which is the nominator stopping rather than the agency prohibiting. It now sits on the separate list of substances nominated but withdrawn and on no current category list.
Why do some clinics advertise epithalon if no prescriber can write for it?: Because a longevity or anti-ageing clinic operates as a cash wellness business and its menu is not constrained the way a pharmacy's is. If you meet one offering it, ask where the material came from, whether a certificate exists for that specific lot, and whether it includes an endotoxin result. Those three questions separate the operations that have checked from the ones that have not.
Is buying epitalon without prescription different from buying epithalon?: No. The two spellings refer to the same molecule, PubChem CID 219042. Regulatory documents use Epitalon and storefronts use Epithalon, which is why searching only one spelling gives you half the picture.
Does the research-use label mean the seller is doing something underhand?: Not by itself. It is the accurate legal description of what is being sold and a seller who sticks to it is being straight with you. The signal to watch for is the opposite: a research-use legend on the vial and human dosing advice on the website, which means the seller knows the rules and has decided the marketing matters more.

The short version

Epithalon without prescription is not a workaround, because no prescription exists in the United States to work around. There is no FDA approval, and the compounding route closed when the epitalon nomination, having been placed in category 2 under the interim policies, was withdrawn by the nominator, leaving the substance on no current category of the 503A bulks list as of 14 May 2026. What remains is a research-use sale with no prescriber, no manufacturing standard and no recourse over the contents, and one certificate to read before you pay. That certificate, on batch 15-05260628, is unusually complete and honest enough to publish a 9.64 mg fill against a 10 mg label. What it cannot do is answer the FDA's actual objection, which is that the agency lacks sufficient information to know whether epitalon would cause harm if administered to humans.